Infliximab efficiency and failure [2] (multiple letters)

Annals of the Rheumatic Diseases

Volumn 63, Issue 6, 2004, Pages 751-752

  Rozin, A P ^a   Andonopoulos, A P ^b,c   Meimaris, N ^b   Daoussis, D ^b   Bounas, A ^b   Giannopoulos, G ^b  

^a RAMBAM MEDICAL CENTER   (Israel)

^b UNIVERSITY OF PATRAS   (Greece)

^c UNIVERSITY OF PATRAS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ETANERCEPT; INFLIXIMAB; METHOTREXATE;

AUTOIMMUNE DISEASE; CYTOKINE PRODUCTION; DRUG EFFICACY; GIANT CELL ARTERITIS; HUMAN; IMMUNE SYSTEM; IMMUNOGENICITY; LETTER; LONG TERM CARE; LYMPHOCYTE ACTIVATION; MONOTHERAPY; PRIORITY JOURNAL; RELAPSE; REMISSION; RHEUMATIC POLYMYALGIA; RHEUMATOID ARTHRITIS; TREATMENT FAILURE; VASCULITIS; WEGENER GRANULOMATOSIS;

ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; HUMANS; TEMPORAL ARTERITIS; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 2442716566     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (0)